China's Tencent Partners with a UK Firm to Boost AI in Health Space

China's Tencent Holdings is tying up with a technology firm from the United Kingdom called Medopad Ltd to use artificial intelligence for the purpose of improving Parkinson's disease treatment. The company is collaborating with Medopad to develop a system to remotely monitor patients with severe movement disorder. The company said that the basic goal is to allow doctors to set drug doses and modify care without patients having to go to the hospital. Healthcare is increasingly "not only about what happens in the clinic, but what happens in the real world", Wei Fan, Tencent's executive director for medical AI research said. "The reason we want to work with Medopad is they're experts in monitoring patients."